Saratov JOURNAL of Medical and Scientific Research
Home

Cardiometabolic risk factors in women experienced thrombosis at a young age

Year: 2024, volume 20 Issue: №1 Pages: 34-40
Heading: Cardiology Article type: Original article
Authors: Movchan T.V., Vereina N.K.
Organization: South Ural State Medical University
Summary:

Objective: to assess the presence of cardiometabolic risk factors in women who have suffered arterial or venous thrombosis at a young age. Material and methods. The type of study is a "cross-section" based on a prospective observational study. The main group included 49 women aged 18-44 who had undergone instrumental^ verified arterial or venous thrombosis at least 1 year ago. The median follow-up was 80.3 months [50.1; 96.2] months. The control group included 24 practically healthy female volunteers in the same age range. All patients underwent a comprehensive laboratory examination, bioimpedance measurement and oscillographic sphygmography Results. Women with a history of thrombosis had higher levels of LDL cholesterol (3.4±0.8 vs 2.6±0.6 mmol/L); lipoprotein (a) (90.6±7.4 vs56.9±6.5 mg/dl) and adiponectin (10.4±4.3 vs 8.2±3.6 mcg/ml); lower levels of cholesterol HDL(1.5±0.4 vs 1.8±0.4 mmol/l) (0.049>p>0.001). The incidence of visceral obesity in this group was 76.2% vs 37.5% in the control group (p<0.001). The total number of cardiovascular risk factors in these patients averaged 2.7±0.1 vs 1.4±0.2 in the control group (p=0.0001). In the main group, an increase in the cardio-ankle vascular index was revealed 6.85±0.95 vs 6.20±0.51 (p=0.044) in women without thrombosis. Only in the group with thrombosis patients have a decrease in LPK0.9 and an increase in the CAVI index>8 (18,5 vs 0% in the control; p=0.025). Conclusion. Young women with a history of thrombosis are characterized by a more burdened profile of cardiometabolic risk factors, a higher incidence of visceral obesity and increased vascular wall stiffness compared with women without thrombosis of the same age group.

Keywords: young women, cardiometabolic risk factors, bioimpedance analysis, arterial and venous thrombosis

Bibliography:
1. Ekker MS, Verhoeven Jl, Vaartjes I, et al. Stroke incidence in young adults according to age, subtype, sex, and time trends. Neurology. 2019; 92 (21): e2444-54. DOI: 10.1212/ WNL.0000000000007533
2. Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first — ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009; 40 (4): 1195-203. DOI: 10.1161/STROKEAHA
3. Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA. 1972; 221 (7): 661-6. PMID: 4261853
4. Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019; 139(8): 1047-56. DOI: 10.1161/CIRCULATIONAHA.118.037137
5. Weill A, Dalichampt M, Raguideau F, et al. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: Cohort study. BMJ. 2016; 353: i2002. DOI: 10.1136/bmj. i2002
6. Heinemann LA, Dinger JO Range of published estimates of venous thromboembolism incidence in young women. Contraception. 2007; 75 (5): 328-36. DOI: 10.1016/j. contraception.2006.12.018
7. Prandoni P. Venous and arterial thrombosis: Is there a link? Adv Exp Med Biol. 2017; 906: 273-83. DOI: 10.1007/5584_2016_121
8. Lind C, Flinterman LE, Enga KF, et al. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases. Circulation. 2013; 129 (8): 855-63. DOI: 10.1161/ CIRCULATIONAHA.113.004168
9. Maino A, Algra A, Peyvandi F, et al. Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: A cohort study. ВМС Cardiovasc Disord.2019; 19(1): 55. DOI: 10.1186/s12872-019-1040-4
10. Kobalava ZhD, Konradi АО, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020; 25 (3): 3786 DOI: 10.15829/1560-4071 -2020-3-3786
11. Arabidze GG, Zhloba АА, Roitman АР. Laboratory diagnosis of lipid metabolism disorders and the development of atherosclerosis. Atherosclerosis and Dyslipidemia. 2021; 4 (45): 5-16DOI: 10.34687/2219-8202.JAD.2021.04.0001
12. Kukharchuk VV, Ezhov MV, Sergienko IV, et al. Eurasian Association of Cardiology (EAC)/Russian National Atherosclerosis Society (RNAS, Russia) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2020). Eurasian Heart Journal. 2020; 2 (31): 6-29 DOI: 10.38109/2225-1685-2020-2-6-29.
13. Simikas S, Fazio S, Ferdinand КС, et al. NHLBI Working Group Recommendations to Reduce Lipoprotein (a) — Mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol. 2018; 16; 71 (2): 177-92. DOI: 10.1016/j.jacc. 2017.11.014 14. Tanaka A, Tomiyama H, MaruhashiT, et al.; Physiological Diagnosis Criteria for Vascular Failure Committee. Physiological diagnostic criteria for vascular failure. Hypertension. 2018; 72 (5): 1060-71. DOI: 10.1161/HYPERTENSIONAHA.118.11554
15. Drapkina OM, Maksimova OA, Sheptulina AF, Dzhioeva ON. Bioimpedance analysis of body composition: What should general practitioner know? Russian Journal of Preventive Medicine and Public Health. 2022; 25 (10): 91-6. DOI: 10.17116/profmed20222510191
16. Kytikova OY, Antonyuk MV, Kantur ТА, et al. Prevalence and biomarkers of metabolic syndrome. Obesity and Metabolism. 2021; 18(3): 302-12. DOI: 10.14341 /ometl 2704
17. Lavrenova ЕА, Drapkina ОМ. Insulin resistance in obesity: Pathogenesis and effects. Obesity and Metabolism. 2020; 17 (1): 48-55. DOI: 10.14341/omet9759
18. Oganov RG, Simanenkov VI, Bakulin IG, et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019; 18 (1): 5-66. DOI: 10.15829/1728-8800-2019-1 -5-66
19. Kirichenko TV, Markina YV, Bogatyreva Al, et al. The role of adipokines in inflammatory mechanisms of obesity. Int J Mol Sci. 2022; 23 (23): 14982. DOI: 10.3390/ijms232314982
20. Miyoshi T, Ito H. Arterial stiffness in health and disease: The role of cardio-ankle vascular index. J Cardiol. 2021; 78 (6): 493-501. DOI: 10.1016/j.jjcc.2021.07.011
21. Vasyuk YuA, Ivanova SV, Shkolnik EL, et al. Consensus opinion of Russian experts on the assessment of arterial stiffness in clinical practice. Cardiovascular Therapy and Prevention. 2016; 15 (2): 4-19. DOI: 10.15829/1728-8800-2016-2-4-19

AttachmentSize
2024_01_034-040.pdf354.02 KB
All articles of the authors: Vereina N.K. , Movchan T.V.

No votes yet